200 related articles for article (PubMed ID: 17703434)
1. Low-dose renin inhibitor and low-dose AT(1)-receptor blocker therapy ameliorate target-organ damage in rats harbouring human renin and angiotensinogen genes.
Dechend R; Shagdarsuren E; Gratze P; Fiebeler A; Pilz B; Meiners S; Derer W; Feldman DL; Webb R; Muller DN
J Renin Angiotensin Aldosterone Syst; 2007 Jun; 8(2):81-4. PubMed ID: 17703434
[TBL] [Abstract][Full Text] [Related]
2. Renin inhibition in hypertension.
Gradman AH; Kad R
J Am Coll Cardiol; 2008 Feb; 51(5):519-28. PubMed ID: 18237679
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of the renin angiotensin aldosterone system: focus on aliskiren.
Rao MS
J Assoc Physicians India; 2010 Feb; 58():102-8. PubMed ID: 20653151
[TBL] [Abstract][Full Text] [Related]
4. Direct renin inhibition with aliskiren in hypertension and target organ damage.
Müller DN; Luft FC
Clin J Am Soc Nephrol; 2006 Mar; 1(2):221-8. PubMed ID: 17699210
[TBL] [Abstract][Full Text] [Related]
5. Persistent antihypertensive effect of aliskiren is accompanied by reduced proteinuria and normalization of glomerular area in Ren-2 transgenic rats.
Rakusan D; Kujal P; Kramer HJ; Husková Z; Vanourková Z; Vernerová Z; Mrázová I; Thumová M; Cervenka L; Vanecková I
Am J Physiol Renal Physiol; 2010 Oct; 299(4):F758-66. PubMed ID: 20668096
[TBL] [Abstract][Full Text] [Related]
6. Aliskiren, the future of renin-angiotensin system blockade?
Uresin Y; Mehtar Bozkurt M; Sabirli S; Ozunal ZG
Expert Rev Cardiovasc Ther; 2007 Sep; 5(5):835-49. PubMed ID: 17867914
[TBL] [Abstract][Full Text] [Related]
7. Renin inhibitors: novel agents for renoprotection or a better angiotensin receptor blocker for blood pressure lowering?
Pimenta E; Oparil S
Cardiol Clin; 2008 Nov; 26(4):527-35. PubMed ID: 18929229
[TBL] [Abstract][Full Text] [Related]
8. Renin inhibition ameliorates renal damage through prominent suppression of both angiotensin I and II in human renin angiotensinogen transgenic mice with high salt loading.
Yoshida S; Ishizawa K; Ayuzawa N; Ueda K; Takeuchi M; Kawarazaki W; Fujita T; Nagase M
Clin Exp Nephrol; 2014 Aug; 18(4):593-9. PubMed ID: 24154707
[TBL] [Abstract][Full Text] [Related]
9. Aliskiren, a human renin inhibitor, ameliorates cardiac and renal damage in double-transgenic rats.
Pilz B; Shagdarsuren E; Wellner M; Fiebeler A; Dechend R; Gratze P; Meiners S; Feldman DL; Webb RL; Garrelds IM; Jan Danser AH; Luft FC; Müller DN
Hypertension; 2005 Sep; 46(3):569-76. PubMed ID: 16103264
[TBL] [Abstract][Full Text] [Related]
10. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
Weir MR
Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
[TBL] [Abstract][Full Text] [Related]
11. Renal and hormonal responses to direct renin inhibition with aliskiren in healthy humans.
Fisher ND; Jan Danser AH; Nussberger J; Dole WP; Hollenberg NK
Circulation; 2008 Jun; 117(25):3199-205. PubMed ID: 18559696
[TBL] [Abstract][Full Text] [Related]
12. [What is renin inhibition? Mechanism of action].
Timurkaynak T
Turk Kardiyol Dern Ars; 2009 Oct; 37 Suppl 7():5-14. PubMed ID: 20019471
[TBL] [Abstract][Full Text] [Related]
13. The direct renin inhibitor aliskiren improves vascular remodelling in transgenic rats harbouring human renin and angiotensinogen genes.
Savoia C; Arrabito E; Parente R; Sada L; Madaro L; Nicoletti C; Zezza L; Alonzo A; Rubattu S; Michelini S; Muller DN; Volpe M
Clin Sci (Lond); 2013 Aug; 125(4):183-9. PubMed ID: 23438195
[TBL] [Abstract][Full Text] [Related]
14. Aliskiren: renin inhibitor for hypertension management.
Cheng JW
Clin Ther; 2008 Jan; 30(1):31-47. PubMed ID: 18343241
[TBL] [Abstract][Full Text] [Related]
15. Aliskiren: an oral direct renin inhibitor for the treatment of hypertension.
Sanoski CA
Pharmacotherapy; 2009 Feb; 29(2):193-212. PubMed ID: 19170589
[TBL] [Abstract][Full Text] [Related]
16. Activation of renin-angiotensin system induces osteoporosis independently of hypertension.
Asaba Y; Ito M; Fumoto T; Watanabe K; Fukuhara R; Takeshita S; Nimura Y; Ishida J; Fukamizu A; Ikeda K
J Bone Miner Res; 2009 Feb; 24(2):241-50. PubMed ID: 18847324
[TBL] [Abstract][Full Text] [Related]
17. Characterization of a stable, hypertensive rat model suitable for the consecutive evaluation of human renin inhibitors.
St-Jacques R; Toulmond S; Auger A; Binkert C; Cromlish W; Fischli W; Harris J; Hess P; Jie Lan ; Liu S; Riendeau D; Steiner B; Percival MD
J Renin Angiotensin Aldosterone Syst; 2011 Sep; 12(3):133-45. PubMed ID: 21393355
[TBL] [Abstract][Full Text] [Related]
18. Current concepts: renin inhibition in the treatment of hypertension.
Gradman AH; Pinto R; Kad R
Curr Opin Pharmacol; 2008 Apr; 8(2):120-6. PubMed ID: 18308634
[TBL] [Abstract][Full Text] [Related]
19. Renin inhibition with aliskiren.
Wuerzner G; Azizi M
Clin Exp Pharmacol Physiol; 2008 Apr; 35(4):426-30. PubMed ID: 18307734
[TBL] [Abstract][Full Text] [Related]
20. Renin inhibition: should it supplant ACE inhibitors and ARBS in high risk patients?
Gaddam KK; Oparil S
Curr Opin Nephrol Hypertens; 2008 Sep; 17(5):484-90. PubMed ID: 18695389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
